Cargando…

Natural killer cells in patients with severe chronic fatigue syndrome

Maintenance of health and physiological homeostasis is a synergistic process involving tight regulation of proteins, transcription factors and other molecular processes. The immune system consists of innate and adaptive immune cells that are required to sustain immunity. The presence of pathogens an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenu, E. W., Hardcastle, S. L., Atkinson, G. M., van Driel, M. L., Kreijkamp-Kaspers, S., Ashton, K. J., Staines, D. R., Marshall-Gradisnik, S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389023/ https://www.ncbi.nlm.nih.gov/pubmed/26000145 http://dx.doi.org/10.1007/s13317-013-0051-x

Ejemplares similares

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2012)

Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Huth, T. K., et al.
Publicado: (2016)

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2011)

Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

High-Throughput Sequencing of Plasma MicroRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W., et al.
Publicado: (2014)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis
por: Johnston, Samantha C, et al.
Publicado: (2014)

Immune and hemorheological changes in Chronic Fatigue Syndrome
por: Brenu, Ekua W, et al.
Publicado: (2010)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Peterson, D., et al.
Publicado: (2015)

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Eaton-Fitch, Natalie, et al.
Publicado: (2019)

Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels
por: Nguyen, T., et al.
Publicado: (2016)

Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Marshall-Gradisnik, Sonya, et al.
Publicado: (2016)

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
por: Eaton, Natalie, et al.
Publicado: (2018)

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Cabanas, Helene, et al.
Publicado: (2019)

A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
por: Brenu, Ekua W., et al.
Publicado: (2016)

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Cabanas, Hélène, et al.
Publicado: (2018)

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Eaton-Fitch, Natalie, et al.
Publicado: (2022)

Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients
por: Nguyen, T., et al.
Publicado: (2016)

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients
por: Cabanas, H., et al.
Publicado: (2019)

Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Staines, Donald R, et al.
Publicado: (2009)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Heat Shock Proteins and Regulatory T Cells
por: Brenu, E. W., et al.
Publicado: (2013)

Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Du Preez, Stanley, et al.
Publicado: (2023)

A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
por: Du Preez, S., et al.
Publicado: (2018)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Postulated Role of Vasoactive Neuropeptide-Related Immunopathology of the Blood Brain Barrier and Virchow-Robin Spaces in the Aetiology of Neurological-Related Conditions
por: Staines, D. R., et al.
Publicado: (2008)

Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2021)

Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review
por: Campagnolo, N., et al.
Publicado: (2017)

Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans
por: Thapaliya, Kiran, et al.
Publicado: (2020)

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Balinas, Cassandra, et al.
Publicado: (2019)

The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort
por: Close, Shara, et al.
Publicado: (2020)

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Staines, Donald R, et al.
Publicado: (2009)

Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome
por: Kujawski, Sławomir, et al.
Publicado: (2021)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Chacko, Anu, et al.
Publicado: (2016)

Intra brainstem connectivity is impaired in chronic fatigue syndrome
por: Barnden, Leighton R, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sbobd7ets0jjdvd7vduvgu0bbd